Clinical Trials Logo

Clinical Trial Summary

This double-masked multi-center trial will evaluate the association of diabetes in the cornea donor with transplant success and loss of endothelial cells one year following Descemet membrane endothelial keratoplasty (DMEK). Study eyes will be assigned to receive either a cornea from a donor without diabetes or a cornea from a donor with diabetes.


Clinical Trial Description

This study will address concerns about the suitability of corneas from donors with diabetes for use with DMEK through a prospective, masked, multi-center clinical trial in which the donor corneas are assigned by diabetes status in the same distribution proportion (2:1 distribution of tissue from donors without diabetes to tissue from donors with diabetes) currently used in the USA. The DEKS will assess graft success and endothelial cell density through 1 year following DMEK to determine whether the surgical success rate with corneas from donors with well characterized diabetes (including post-mortem hemoglobin A1c (HbA1c) and advanced glycation endproducts (AGE) testing) is inferior to the rate with donors without diabetes. The investigators hypothesize that the majority of donor corneas from individuals with diabetes will be suitable, but that a portion of donors with a higher diabetes severity scale, and/or poorer control based on HbA1c will have a greater risk for graft failure and endothelial cell loss. This study will also examine collected skin biopsies to determine whether high levels of AGE biomarkers in donor skin tissue - which quantifies disease severity over many years (and possibly coupled with elevated HbA1c levels) - is associated with greater risk for graft failure and cell loss. This novel approach to characterization of donor tissue can provide a paradigm shift in the risk assessment of transplanted corneas from diabetic donors. The effect of recipient diabetes on keratoplasty success and cell loss will also be studied in a rigorous manner to determine the potential combined effect of donor and recipient diabetes status. In summary, this study is designed to determine if non-diabetic donor corneas are superior to diabetic donor corneas in terms of both graft success and endothelial cell density outcomes, with an additional specific aim to determine whether donors with a higher diabetes severity scale, and/or poorer control based on HbA1c are driving the effect. This study will also determine whether a high AGE/A1c metric is also associated with the potential superiority finding and establish a novel composite score (severity score, HbA1c and AGE/A1c) based on these metrics that can be used to identify high versus low risk diabetic donors. This distinction may enable eye banks to potentially utilize the majority of donors with diabetes for EK surgery, while excluding the severely affected donors with diabetes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05134480
Study type Interventional
Source Case Western Reserve University
Contact Loretta Szczotka-Flynn, OD, PhD
Phone 216-844-7984
Email Loretta.Szczotka-Flynn@uhhospitals.org
Status Recruiting
Phase Phase 3
Start date January 21, 2022
Completion date March 30, 2025

See also
  Status Clinical Trial Phase
Completed NCT03248037 - Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation Phase 3
Recruiting NCT03275896 - Evaluation of the Efficacy of Descemet Membrane Transplantation for the Treatment of Fuchs' Endothelial Dystrophy Early Phase 1
Completed NCT02332109 - ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy N/A
Completed NCT02470793 - Technique And Results In Endothelial Keratoplasty N/A
Recruiting NCT01206127 - DSAEK- Postoperative Positioning and Transplant Dislocation N/A
Recruiting NCT03407755 - Air Versus SF6 for Descemet's Membrane Endothelial Keratoplasty (DMEK) N/A
Completed NCT04140422 - Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea N/A
Recruiting NCT06048380 - The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery Phase 3
Completed NCT02793310 - DMEK Versus DSAEK Study N/A
Completed NCT01795001 - The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy
Completed NCT04057053 - Netarsudil Use After Descemetorhexis Without Endothelial Keratoplasty Early Phase 1
Terminated NCT01361282 - Using the Optovue OCT to Select IOL Power N/A
Completed NCT02542644 - Assessment of Corneal Graft Attachment in Patients With Fuchs Endothelial Corneal Dystrophy Following DMEK Using Ultra-high Resolution OCT N/A
Recruiting NCT04191629 - Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema Phase 1
Completed NCT05399095 - Supine Positioning for Graft Attachment After Descemet Membrane Endothelial Keratoplasty N/A
Completed NCT04752020 - Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty Early Phase 1
Not yet recruiting NCT05716945 - The OPTIMISE Study Phase 4
Recruiting NCT03575130 - Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy Phase 2
Recruiting NCT02118922 - A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
Completed NCT04420429 - The Effect Of Preoperative Parameters On Success After DMEK Surgery